T2C2 CAPITAL
T2C2 (Technology, Transfer, Commercialisation, Capital) has the mission to identify in Universities, Research Centres and Industry, business opportunities and turn them into real businesses. Outstanding science, high-quality entrepreneurs, intellectual property and commercial potential are the key elements and criteria that are used to select projects. T2C2 gets involved in the seed phase to support the continuation of the research and to develop the business engineering of the project. Following the seed phase, T2C2 participates with other investors in the financing of the following rounds.
T2C2 CAPITAL
Founded:
1997-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Font API Amazon DoubleClick.Net CloudFront AWS Global Accelerator AdBlock Acceptable Ads Trellian
Similar Organizations
University of Tuebingen
Tuebingen University is a German public research university.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2006-10-25 | Cytheris | T2C2 Capital investment in Series B - Cytheris | 30.7 M USD |
| 2006-07-24 | TransPharma Medical | T2C2 Capital investment in Series C - TransPharma Medical | 18 M USD |
| 2005-10-10 | Topigen Pharmaceuticals | T2C2 Capital investment in Series B - Topigen Pharmaceuticals | 6 M CAD |
| 2005-05-20 | BioAxone Therapeutic | T2C2 Capital investment in Series B - BioAxone Therapeutic | 12.15 M USD |
| 2005-01-18 | Enobia Pharma | T2C2 Capital investment in Series A - Enobia Pharma | 15.55 M USD |
| 2004-12-01 | Topigen Pharmaceuticals | T2C2 Capital investment in Venture Round - Topigen Pharmaceuticals | 22.6 M CAD |
| 2003-11-26 | Chronogen | T2C2 Capital investment in Series B - Chronogen | 17 M CAD |
| 2003-11-05 | IatroQuest Corporation | T2C2 Capital investment in Venture Round - IatroQuest Corporation | 15 M CAD |
| 2001-12-18 | Cytochroma | T2C2 Capital investment in Series B - Cytochroma | 3.5 M CAD |
| 2001-10-05 | Interomex BioPharmaceuticals | T2C2 Capital investment in Series B - Interomex BioPharmaceuticals | 4 M USD |
More informations about "T2C2 Capital"
T2C2 Capital - Investments, Portfolio & Company Exits - Crunchbase
T2C2 (Technology, Transfer, Commercialisation, Capital) has the mission to identify in Universities, Research Centres and Industry,See details»
T2C2 Capital - Golden
T2C2 Capital A venture capital and private equity firm investing in healthcare, information technology, business products, and services sectors. Overview Structured Data Issues …See details»
T2C2 Capital - Investor Profile, Portfolio & Team - Tracxn
3 days ago Co-investors of T2C2 Capital. Over the past . 23 years, 26 investors have co-invested in T2C2 Capital's portfolio companies.. This includes only funds.Top Co-investors of …See details»
T2C2 investment portfolio - PitchBook
T2C2 General Information Company Description. T2C2 Capital is a venture capital firm based out in Montreal, Canada. The firm seeks to invest in healthcare, information technology & business products and services sectors. The firm's …See details»
T2C2 Capital Company Profile | Management and Employees List
Find contact information for T2C2 Capital. Learn about their Venture Capital & Private Equity, Finance market share, competitors, and T2C2 Capital's email format. Company Overview. …See details»
T2C2 Capital investor portfolio, rounds & team - Dealroom.co
T2C2 Capital Venture capital Claimed. T2C2 (Technology, Transfer, Commercialisation, Capital) has the mission to identify in Universities, Research Centres and Industry,. Overview. Portfolio …See details»
T2C2 Capital - Investments, Portfolio & Exits - Tracxn
T2C2 Capital has a portfolio of 6 companies. They have 2 portfolio exits.See details»
T2C2 Capital | Institution Profile - Private Equity International
T2C2 Capital was a Canada-based venture capital specialist focused on healthcare and bio-tech related companies. AUM. Get access to T2C2 Capital total AUM > Headquarters: Montreal, …See details»
T2C2 Capital - Tech Stack, Apps, Patents & Trademarks - Crunchbase
T2C2 (Technology, Transfer, Commercialisation, Capital) has the mission to identify in Universities, Research Centres and Industry,See details»
T2C2 Capital - CB Insights
Dec 31, 1997 T2C2 Capital is a venture capital firm based in Montreal, Quebec. Use the CB Insights Platform to explore T2C2 Capital's full profile. T2C2 Capital Portfolio Investments, …See details»
T2C2 Capital - Co-Investors - Tracxn
18 investors have invested with T2C2 Capital. 8 investors have invested after T2C2 Capital.See details»
T2C2 Capital - VC DATALAB profile - data.kando.tech
Investment activity status. Active investorSee details»
T2C2 Capital — 11 Investments, 5 Exits, 10 Portfolio companies ...
T2C2 Capital. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom list of funds. …See details»
T2C2 Capital - Angel Investors List | MyCapital
View T2C2 Capital contact details including email address and LinkedIn URL in angel investors list at MyCapital.com. Use our online tool to message 3,000 investors in minutes.See details»
Gestion T2C2/Info Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Gestion T2C2/Info Inc of Montréal, QC. Get the latest business insights from Dun & Bradstreet. …See details»
T2C2 Capital - Investor Venture Capital - Venture Capital
Altdaq.com is a venture marketplace providing members access to marketing and investor relations solutions to attract capital and talent. Altdaq.com is not an investment or financial …See details»
Capital That Works! Pension Funds and Alternative Strategies for ...
One illustration of Sofinov’s external participation is seen in the comparably-mandated Technocap, in which CDP is joined by two other pension funds, Bombardier Pension Trust and …See details»
Quazal Technologies - Funding, Financials, Valuation & Investors
Societe Innovatech du Grand Montreal and T2C2 Capital are the most recent investors. Unlock for free . Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 1. Total …See details»
Topigen Pharmaceuticals - Funding, Financials, Valuation & Investors
Caisse de Depot et Placement du Quebec and T2C2 Capital are the most recent investors. Topigen Pharmaceuticals has acquired Anagenis on Mar 25, 2004. Unlock for free . Funding …See details»